Skip to main content
Displaying 13 - 17 of 17
Display:
12
24
48
Liver Tumours
5
Bayer: Addressing a Changing Treatment Dynamic in HCC: Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Bayer: Addressing a Changing Treatment Dynamic in HCC: Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Bayer: Addressing a Changing Treatment Dynamic in HCC: Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Bayer: Addressing a Changing Treatment Dynamic in HCC: Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Bayer: Addressing a Changing Treatment Dynamic in HCC: Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy
